Thiago Costa Ribeiro

Thiago Costa Ribeiro

Auto-generated profile, based on publicly available information

Thiago Costa Ribeiro

Universidade de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
RJRicardo Jureidini
Ricardo Jureidini
GNGuilherme Naccache Namur
Guilherme Naccache Namur
TRThiago Costa Ribeiro
Thiago Costa Ribeiro
TBTelesforo Bacchella
Telesforo Bacchella
LSLucas Stolzemburg
Lucas Stolzemburg
ICIvan Cecconello
Ivan Cecconello
BACKGROUND: Minimally invasive distal pancreatectomy (MIDP) is associated with less blood loss and faster functional recovery. However, the benefits of robotic assisted distal pancreatectomy (RDP) over laparoscopic distal pancreatectomy (LDP) are unknown. AIMS: To compare RDP versus LDP for surgical treatment of benign lesions, pre-malignant and borderline malignant pancreatic neoplasias. METHODS: This is a retrospective study comparing LDP with RDP. Main outcomes were overall morbidity and overall costs. Secondary outcomes were pancreatic fistula (PF), infectious complications, readmission, operative time (OT) and length of hospital stay (LOS). RESULTS: Thirty patients submitted to LDP and 29 submitted to RDP were included in the study. There was no difference regarding preoperative characteristics. There was no difference regarding overall complications (RDP – 72,4% versus LDP – 80%, p=0,49). Costs were superior for patients submitted to RDP (RDP=US$ 6,688 versus LDP=US$ 6,149, p=0,02), mostly due to higher costs of surgical materials (RDP=US$ 2,364 versus LDP=1,421, p=0,00005). Twenty-one patients submitted to RDP and 24 to LDP developed pancreatic fistula (PF), but only 4 RDP and 7 LDP experienced infectious complications associated with PF. OT (RDP=224 min. versus LDP=213 min., p=0.36) was similar, as well as conversion to open procedure (1 RDP and 2 LDP). CONCLUSIONS: The postoperative morbidity of robotic distal pancreatectomy is comparable to laparoscopic distal pancreatectomy. However, the costs of robotic distal pancreatectomy are slightly higher.

1 January 2024 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
LSLucas Cata Preta Stolzemburg
Lucas Cata Preta Stolzemburg
Francisco TustumiFrancisco Tustumi
Francisco Tustumi
TRThiago Costa Ribeiro
Thiago Costa Ribeiro
RJRicardo Jureidini
Ricardo Jureidini
MSMauricio Paulin Sorbello
Mauricio Paulin Sorbello
GNGuilherme Naccache Namur
Guilherme Naccache Namur
BACKGROUND: The unresectable pancreatic head tumors develop obstructive jaundice and cholestasis during follow-up. Cholestasis is associated with complications and treatment options are endoscopic stenting (ES) and biliary bypass surgery (BBS). AIMS: The aim of the current study was to compare the safety and efficacy of biliary bypass surgery (BBS) and endoscopic stenting (ES) for cholestasis in advanced pancreas cancer. METHODS: This is a retrospective cohort of patients with cholestasis and unresectable or metastatic pancreas cancer, treated with BBS or ES. Short and long-term outcomes were evaluated. We considered the need for hospital readmission due to biliary complications as treatment failure. RESULTS: A total of 93 patients (BBS=43; ES=50) were included in the study. BBS was associated with a higher demand for postoperative intensive care (37 vs.10%; p=0.002, p<0.050), longer intensive care unit stay (1.44 standard deviation±2.47 vs. 0.66±2.24 days; p=0.004, p<0.050), and longer length of hospital stay (7.95±2.99 vs. 4.29±5.50 days; p<0.001, p<0.050). BBS had a higher risk for procedure-related complications (23 vs. 8%; p=0.049, p0.050). ES was independently associated with a higher risk for treatment failure than BBS on multivariate analysis (hazard ratio 3.97; p=0.009, p<0.050). CONCLUSIONS: BBS is associated with longer efficacy than ES for treating cholestasis in advanced pancreatic cancer. However, the BBS is associated with prolonged intensive care unit and hospital stays and higher demand for intensive care.

1 January 2024 in Autopsy Case Reports
Verified
Journal Article
Open access
PDF file
GMGabriela Del Angel Millán
Gabriela Del Angel Millán
JJJosé Jukemura
José Jukemura
JBJúlia Bragion Bicudo
Júlia Bragion Bicudo
RJRicardo Jureidini
Ricardo Jureidini
AMAndré Luís Montagnini
André Luís Montagnini
EFEstela Regina Ramos Regina Ramos Figueira
Estela Regina Ramos Regina Ramos Figueira
Autops Case Rep, vol.14, e2024516, 2024

1 January 2026 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
DMDanny Michell Conde Monroy
Danny Michell Conde Monroy
GNGuilherme Naccache Namur
Guilherme Naccache Namur
Francisco TustumiFrancisco Tustumi
Francisco Tustumi
LSLucas Cata Preta Stolzemburg
Lucas Cata Preta Stolzemburg
RJRicardo Jureidini
Ricardo Jureidini
TRThiago Costa Ribeiro
Thiago Costa Ribeiro
Background: Central pancreatectomy (CP) is a parenchyma-sparing alternative to standard resections for benign or low-grade lesions of the pancreatic neck. While it aims to preserve endocrine and exocrine function, it is associated with significant technical complexity and high rates of postoperative pancreatic fistula (POPF). Aims: To analyze the CP at a single high-volume Brazilian center. Methods: A retrospective analysis of a prospectively maintained database was conducted. All patients undergoing CP at a single high-volume Brazilian center between January 2009 and December 2024 were included. Data on demographics, operative details, pathology, complications (International Study Group of Pancreatic Surgery – ISGPS/Clavien-Dindo criteria), and long-term pancreatic function were collected. Results: Twenty-two patients underwent CP (mean age 54 years, 72% female). The majority of lesions were cystic (50%) or neuroendocrine tumors (36.4%). The POPF rate was 86.4%, all Grade B, most managed conservatively via prolonged drainage. No Grade C fistulas, postoperative hemorrhages, or mortality occurred. Delayed gastric emptying occurred in 22.7%. After a median follow-up of 5.59 years, endocrine insufficiency developed in 9% of patients without prior diabetes (none insulin-dependent), and exocrine insufficiency in 13.6%. Only one locoregional recurrence was observed (isolated metastasis). Conclusions: This first Latin American series demonstrates that central pancreatectomy is a feasible and effective parenchyma-sparing procedure. It provides excellent long-term preservation of pancreatic function with low severe morbidity, despite high rates of manageable POPF. These outcomes support its role as a valuable surgical option for selected patients in experienced centers.

11 June 2025 in Clinics
Verified
Journal Article
Open access
GNGuilherme Naccache Namur
Guilherme Naccache Namur
FMFernanda Lopez Mazzucato
Fernanda Lopez Mazzucato
RJRicardo Jureidini
Ricardo Jureidini
TRThiago Costa Ribeiro
Thiago Costa Ribeiro
MRManoel de Souza Rocha
Manoel de Souza Rocha
UJUlysses Ribeiro Junior
Ulysses Ribeiro Junior
Pancreatic Fistula (PF) is a major complication following Pancreatoduodenectomy (PD), making its prediction crucial for individualized treatment. The aim of this study is to develop a preoperative nomogram to predict PF after PD. From January 2009 to January 2018, patients who underwent PD were reviewed. Variables with p < 0.1 from univariate analysis were selected for a multivariate analysis. Variables with p < 0.05 were then included in the nomogram, which was internally validated in a different group of patients. 262 patients underwent PD during the period of the study. The risk factors for PF identified in the derivation group were male gender (OR = 2.89), higher BMI (OR = 1.14) and pancreatic duct diameter ≤ 3 mm (OR = 3.52). Preoperative weight loss exceeding 10 % within six months was protective against PF (OR = 0.16). A preoperative nomogram incorporating these four variables was developed and demonstrated good performance in the validation set, with an area under the ROC curve of 0.798. male gender, a main pancreatic duct ≤ 3 mm and higher BMI are risk factors for PF, while weight loss is protective. The developed nomogram accurately predicts PF occurrence using these variables.